North America

1
North America

• Company Profile 2009

2
North America At a Glance
Focus on RD Invested EUR 5.5 billion from
20002008
Sales EUR 8.0 billion Legal Entities 42 Employ
ees 17,065 Manufacturing Sites 27
Number of employees in full-time equivalents
As of December 31, 2008
3
North America Historical Highlights
1865 First Bayer operations in the United
States 1955 Bayer begins to operate in Canada
1999 100th anniversary of Aspirin 2000
Making Science Make Sense program honored with
the Presidents Service Award 2008 Award
from the National Science Board in recognition of
the Making Science Make Sense program
1865
2008
4
North America Key Locations
Administration / Marketing
Manufacturing Sites
Research Development
West Haven,Connecticut
Regina,Saskatchewan
Saskatoon,Saskatchewan
Montreal,Québec
Calgary,Alberta
Toronto,Ontario
Puget Sound,Washington
Muskegon,Michigan
Kansas City,Missouri
Shawnee,Kansas
Deerfield, Massachusetts
Berkeley,California
Mishawaka,Indiana
Tarrytown,New York
Sunnyvale,California
Myerstown, Pennsylvania
Stilwell,Kansas
Wayne, Montville,New Jersey
Pittsburgh, Pennsylvania
Hebron,Ohio
New Martinsville, West Virginia
Institute, West Virginia
Morristown,New Jersey
Baytown, Channelview, Texas
South Charleston, West Virginia
Research Triangle Park, North Carolina
As of December 31, 2008
5
North America Business Structure
Breakdown of Total Sales by Subgroup 2008
MaterialScience 26
HealthCare 56
EUR8.0 billion
CropScience 18
As of December 31, 2008
6
North America Capital Expenditures and
Research Development

• In the Last Nine Years (20002008)

Capital Expenditures
EUR 4.4 billion
Research and Development
EUR 5.5 billion
As of December 31, 2008
7
North America Sustainable DevelopmentEnvironmen
tal Protection and Safety

• Bayer is highly dedicated to protecting and
  improving both human health and the environment
  (Wildlife Habitat Council Awards 2003
  International Corporate Lands Award and 2008
  Signature of Sustainability Site Award)
• High-level environmental policies and practices
  at all Bayer sites (Chicago Climate Exchange)

• Decrease of employee injuries between 1996 and
  2008 by 43 percent at Bayer Corporation
• Bayer North America Corporate Sustainability
  Community Council
• Partnerships with NGOs around sustainability
  and environmental education

8
North America Sustainable DevelopmentCommunity
Involvement

• Bayer has a long, rich tradition of demonstrating
  outstanding corporate social responsibility. A
  sample of our CSR initiatives includes
• Bayer USA Foundation
• Making Science Make Sense Program (three
  Presidential Awards)
• Bayers Disaster Relief Efforts
• Bayers United Way Campaign
• Partnership with United Nations Environment
  Programme
• Bayer Inc. Corporate Responsibility Program
• Employee volunteerism is the backbone of many of
  Bayers CSR initiatives

9
North America Our People

• Bayers set of core values and leadership
  principles has a strong focus on people and
  people development
• Integrity, openness and honesty are fundamental
  standards of the organization
• Besides continuous efforts to embrace workforce
  diversity, Bayer runs programs like
• Bayer Diversity Advisory Council
• Bayers Supplier Diversity Process
• Bayer Women Leaders of the Global Marketplace
  Initiative

10
(No Transcript)
11
Disclaimer
Forward-Looking Statements This presentation
contains forward-looking statements based on
current assumptions and forecasts made by Bayer
Group or subgroup management. Various known and
unknown risks, uncertainties and other factors
could lead to material differences between the
actual assets, financial position, earnings,
development or performance of the company and
the estimates given here. These factors include
those discussed in Bayers public reports, which
are available on the Bayer website at
www.bayer.com. The company assumes no liability
whatsoever to update these forward-looking
statements or to conform them to future events
or developments. Important Information The
names Bayer Schering Pharma or Schering as
used in this presentation always refer to Bayer
Schering Pharma AG, Berlin, Germany, or its
predecessor, Schering AG, Berlin, Germany,
respectively.
As of December 31, 2008